Table 3.

Results of the additional articles published since January 2017, details of previous studies published in Hasenoehrl et al. [5] and Keilani et al. [6]

Additional article	Expansion	Key findings/comments
Taaffe et al. [53] Additional article of Newton et al. [49]	Additional results	↓ Fatigue (EORTC QLQ-C30 fatigue subscale, IRE at 26 and 52 weeks, RAE at 52 weeks, DAE at 52 weeks) ↑ Vitality (SF-36, IRE, RAE and DAE at 52 weeks) ↑ Cardiorespiratory fitness (400mWT, IRE and RAE at 52 weeks, no change in DAE) ↑ Muscle strength (sum of chest press and leg press, IRE at 26 < 52 weeks, RAE at 26 and 52 weeks, DAE at 52 weeks) No group × time interaction
Wall et al. [52] Additional article of Newton et al. [49]	Additional results RAE vs. DAE in the first 26 weeks	↑ Cardiorespiratory capacity (VO2max, RAE) ↑ Fat oxidation (RAE) ↔ RMR ↔ BP ↔ Arterial stiffness ↔ Metabolic profile ↔ PSA and testosterone ↑ Lean tissue mass (RAE) ↓ Fat mass (RAE) Between-group comparison
Fairman et al. [55] Additional article of Galvao et al. [51]	Additional results Training dose, adherence and tolerance	Actual training volume = 77.4% of prescribed Training interrupted (≥3 consecutive sessions missed) in half of patients Training missed (≤2 consecutive sessions missed) in approximately 90% of patients. Training dose modified in approximately 85% of patients
Edmunds et al. [56] Additional article of Galvao et al. [21]	Cost-effectiveness analysis	26 weeks of supervised exercise for prostate cancer survivors probably not cost-effective
Newton et al. [54] Additional article of Taaffe et al. [50]	Additional results	↑ Muscle strength – In IEI at 26 weeks – In DEI at 52 weeks – No difference at 52 weeks ↑ Physical function – 6mWT (only in IEI at 26 weeks) – 400mWT (IEI at 26 weeks, DEI at 52 weeks) – Stair climbing (IEI at 26 weeks, DEI at 52 weeks) – Repeated chair rise (IEI at 26 weeks, DEI at 52 weeks) – Significant difference only for 6mWT at 52 weeks Between-group comparison

IRE impact training and resistance exercise group, RAE resistance and aerobic exercise group, DAE delayed aerobic exercise group, VO₂max maximal oxygen uptake, RMR resting metabolic rate, BP blood pressure, PSA prostate-specific antigen, IEI immediate exercise intervention group, DEI delayed exercise intervention group, 6mWT 6m walk test, 400mWT 400m walk test, ↑ significant increase or improvement, ↓ significant decrease, ↔ no change, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire